USPTO Biotech/Chemical Partnership (BCP) Meetings

We are pleased to announce the USPTO’s next Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCP) Meeting. This BCP meeting expands our long-standing partnership in these industry sectors to customers across the country. The next BCP Meeting will be held on April 26, 2016 in the USPTO Headquarters (Alexandria, VA) as well as available for online participation. This partnership meeting is designed to provide an informal conduit for all stakeholders to share insights and experiences to improve patent prosecution in biotechnology areas. We highly value our customers’ feedback and input, and the individual participation is important in our efforts to continuously improve the quality of our products and services.

Please see below for Registration information on how you can participate.

Date and Location: The Partnership Meeting will be held on April 26th (Tuesday) from 10:00am – 4:00pm at Alexandria, VA.

USPTO Headquarters

Madison Auditorium

600 Dulany Street

Alexandria, VA 22314

The Biotechnology, Chemical and Pharmaceutical Customer Partnership was developed to create a collaborative forum for USPTO customers in these industry sectors to share ideas, experience, and insights with USPTO staff. The BCP is intended to be informal in nature and will include participants from across the industry.

Some of the topics to be discussed by USPTO staff and stakeholders will include:

• International Patent Cooperation Featuring Global Dossier

• Enhancing Patent Claims Quality in Biologics

• Supplemental Examination

• Antibody Written Description

Please check back and click here to view the final BCP Agenda once posted. The USPTO looks forward to hearing the individual views from its customers and does not intend to use this forum to seek or arrive at any consensus. This customer partnership is formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and accordingly, is not established as FACA compliant committee.

10:00 – 10:10am (EST)	Welcoming and Opening Remarks	Mark Powell, Deputy Commissioner, International Patent Cooperation, USPTO   JerryLorengo Director, TC1600, USPTO   Daniel Sullivan Director, TC1600, USPTO   Wanda Walker Director, TC1600, USPTO
10:10 – 11:00am (EST)	International Patent Cooperation Featuring Global Dossier	Jessica Patterson, Program Manager,InternationalPatent Cooperation
11:00 – 11:25am (EST)	Outside Perspectives on International Patent Cooperation	Anthony P.Venturino,Vorys,Sater, Seymour and Pease LLP
11:25–11:30am (EST)	BREAK
11:30am – 12:30pm (EST)	Supplemental Examination	JeanWitz, SPE, Central Reexamine Art Unit, USPTO
12:30–1:30pm (EST)	LUNCH
1:30 – 2:30pm (EST)	Antibody Written Description	Joanne Hama, SPE, TC1600, USPTO
2:30 – 2:40pm (EST)	BREAK	3:00 – 3:10pm (EST)
2:40 – 3:40pm (EST)	Enhancing the Quality of Biologics Patents:  Computational Simulations as Evidence	Brian Lathrop, Law Office of Brian K. Lathrop
3:40 – 3:50pm (EST)	Closing Remarks	Directors, TC1600, USPTO